Reaktionsgleichung
[Cl:1][C:2]1[C:3](F)=[N:4][CH:5]=[C:6]([Cl:8])[CH:7]=1.[CH3:10][C:11]1[CH:12]=[C:13]([CH:18]=[CH:19][C:20]=1[S:21](=[O:35])(=[O:34])[NH:22][CH2:23][C:24]1[CH:25]=[C:26]2[C:30](=[CH:31][CH:32]=1)[N:29]([CH3:33])[CH:28]=[CH:27]2)[C:14]([O:16][CH3:17])=[O:15]>>[Cl:1][C:2]1[C:3]([N:22]([CH2:23][C:24]2[CH:25]=[C:26]3[C:30](=[CH:31][CH:32]=2)[N:29]([CH3:33])[CH:28]=[CH:27]3)[S:21]([C:20]2[CH:19]=[CH:18][C:13]([C:14]([O:16][CH3:17])=[O:15])=[CH:12][C:11]=2[CH3:10])(=[O:34])=[O:35])=[N:4][CH:5]=[C:6]([Cl:8])[CH:7]=1Komponenten
3
Versuchsvorschrift
The titled compound was prepared according to the procedure described in step-2 of Example 1 from 3,5-dichloro-2-fluoropyridine and methyl 3-methyl-4-(N-((1-methyl-1H-indol-5-yl)methyl)sulfamoyl)benzoate (step-2 of Example 11).
Quellen und Nachweise
- ORD-Eintrag
- ord-205196201fb042cb98ce0cd0b4c61632
- Quelldatensatz
- uspto-grants-2014_09
- Patentnummer
- US08829026B2
Verknüpfte Notizen
Wird geladen…